{
  "docId": "019de076-c371-720d-8222-605fb79fc7d9",
  "docSlug": "453b98887d6dc060fc4b3567cc252328",
  "documentTitle": "Bausch Health Companies | Results Presentation Deck | 53 slides",
  "authorId": "bausch-health-companies",
  "authorName": "Bausch Health",
  "documentKindSlug": "conference-presentation",
  "documentKindLabel": "Conference presentation",
  "sourceTypeSlug": "investor_relations",
  "sourceTypeLabel": "Investor relations",
  "presentationDate": "2024-02-01 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.7777778,
  "pageNumber": 6,
  "pageCount": 53,
  "prevPage": 5,
  "nextPage": 7,
  "slideType": "key_takeaways",
  "function": "summarize",
  "density": "overcrowded",
  "nDataPoints": 9,
  "notes": "The slide uses a vertical process-style timeline to organize key business updates.",
  "elementsJson": null,
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019de076-c371-720d-8222-605fb79fc7d9/6",
  "deckHref": "/decks/019de076-c371-720d-8222-605fb79fc7d9",
  "deckJsonHref": "/decks/019de076-c371-720d-8222-605fb79fc7d9.json",
  "deckAnchorHref": "/decks/019de076-c371-720d-8222-605fb79fc7d9#slide-6",
  "components": [
    {
      "bbox": {
        "h": 0.05,
        "w": 0.65,
        "x": 0.038,
        "y": 0.9
      },
      "kind": "disclaimer",
      "text": "1. See Slide 2 for further information on forward-looking statements. 2. This is a non-GAAP measure of non-GAAP ratio. See Slide 3 and Non-GAAP Appendix for further information on non-GAAP measures and ratios.",
      "attrs": null,
      "subkind": null,
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "b8164ff0-27e9-4c74-93f0-c934bcde2963",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.1,
        "w": 0.55,
        "x": 0.2,
        "y": 0.36
      },
      "kind": "list",
      "text": "STRONG R&D PROGRESS: Positive Phase 2 results for Amiselimod; RED-C Phase 3 on track; Thermage FLX and TR-4 approved by NMPA.",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "419e19ca-2ab3-4cc4-9885-4e580702cc86",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.07,
        "w": 0.55,
        "x": 0.2,
        "y": 0.67
      },
      "kind": "list",
      "text": "ANNOUNCED FULL YEAR 2024 GUIDANCE: Solid growth in revenue and Adjusted EBITDA expected in 2024, with increased investment in R&D.",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "46420192-5b89-450f-b16e-ab6de625aedf",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.12,
        "w": 0.55,
        "x": 0.2,
        "y": 0.21
      },
      "kind": "list",
      "text": "SOLID BUSINESS PERFORMANCE IN Q4 & FY 2023: Q4 & FY revenue of $1.24 billion and $4.61 billion, up 3% and 6%; organic growth 2% and 6%; delivered on 2023 guidance.",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "4a5a683c-0552-4a5a-9b83-878c635cc9f3",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.05,
        "w": 0.55,
        "x": 0.2,
        "y": 0.8
      },
      "kind": "list",
      "text": "STRATEGIC ALTERNATIVES: B+L distribution continues to be a strategic priority.",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "eae62629-3e5a-45e1-80ea-81c5ad6a0b49",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.1,
        "w": 0.55,
        "x": 0.2,
        "y": 0.51
      },
      "kind": "list",
      "text": "FOCUS ON BALANCE SHEET: Debt reduced by $670M in 2023; $250M repurchased in Jan 2024; over $1.5B liquidity at year-end.",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "f6db8e20-a017-403a-b26b-1b81328e773b",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.05,
        "w": 0.45,
        "x": 0.038,
        "y": 0.095
      },
      "kind": "title",
      "text": "Bausch Health (excl. B+L) Key Updates",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "0d7763c1-580b-45ee-b856-43cfdb179aaf",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [],
  "frameworks": [],
  "arcBeats": [
    {
      "to": 8,
      "from": 5,
      "beatId": "6aa0ba9d-4e3d-47bd-b277-8bd9e5f65742",
      "arcName": "Monroe's Motivated Sequence",
      "arcSlug": "monroes-sequence",
      "beatName": "Need",
      "beatSlug": "monroes-sequence-need",
      "evidence": "The document highlights key updates and strategic alternatives progress to establish a need for change.",
      "position": 1,
      "confidence": 0.8,
      "parentBeatName": "Complication",
      "parentBeatSlug": "complication"
    }
  ],
  "loops": [],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}